Tempus

formerly Tempus AIIPO

Redefining the future of precision medicine.

Public · Chicago, United States · Founded 2015 · $960.0M raised

Headquarters
Chicago, Illinois
Employees
1001–5000
Founded
2015
Business Model
B2B
Website
tempus.com
Total Funding
$960.0M
Last Round
$200.0M Series G+Oct 2021
Rounds
7
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Tempus AI is a health technology company that uses artificial intelligence and genomic data to enable precision medicine. Founded in 2015 in Chicago, Tempus sequences genomes and analyzes molecular and clinical data to guide treatment decisions in oncology, cardiology, radiology, and pharmacogenomics. The company went public on Nasdaq in June 2024 under ticker TEM.

Summary

Tempus is an Artificial Intelligence company based in Chicago, United States, founded in 2015. It has raised $960.0M in total across 7 rounds, most recently a $200.0M Series G+ round in Oct 2021. Investors include Ares Management, Baillie Gifford and Franklin Templeton.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOJun 2024
$410.7M

Sign up to see all 9 events

Funding: Series C through Series G+. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tempus on Indexed.vc
<a href="https://indexed.vc/companies/tempus"><img src="https://indexed.vc/api/badge/company/tempus" alt="Tempus on Indexed.vc" width="260" height="76" /></a>